Equities

Shield Therapeutics PLC

STX:LSE

Shield Therapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1.55
  • Today's Change-0.10 / -6.06%
  • Shares traded8.52m
  • 1 Year change-78.32%
  • Beta1.4942
Data delayed at least 20 minutes, as of May 03 2024 17:07 BST.
More ▼
DateOpenHighLowCloseVolume
Friday, May 03, 2024Fri, May 03, 20241.651.631.461.558,522,0728.52m
Thursday, May 02, 2024Thu, May 02, 20241.752.001.561.6515,643,32215.64m
Wednesday, May 01, 2024Wed, May 01, 20241.351.801.351.7519,413,98219.41m
Tuesday, April 30, 2024Tue, Apr 30, 20241.351.401.231.3513,350,02713.35m
Monday, April 29, 2024Mon, Apr 29, 20241.351.451.321.355,942,4865.94m
Friday, April 26, 2024Fri, Apr 26, 20241.231.401.201.358,345,8358.35m
Thursday, April 25, 2024Thu, Apr 25, 20241.331.311.061.238,963,3378.96m
Wednesday, April 24, 2024Wed, Apr 24, 20241.431.451.301.332,958,0472.96m
Tuesday, April 23, 2024Tue, Apr 23, 20241.431.431.401.43700,061700.06k
Monday, April 22, 2024Mon, Apr 22, 20241.481.501.401.43705,761705.76k
Friday, April 19, 2024Fri, Apr 19, 20241.481.501.421.481,069,5351.07m
Thursday, April 18, 2024Thu, Apr 18, 20241.481.491.451.48486,264486.26k
Wednesday, April 17, 2024Wed, Apr 17, 20241.531.551.451.484,058,6914.06m
Tuesday, April 16, 2024Tue, Apr 16, 20241.531.551.501.535,113,2855.11m
Monday, April 15, 2024Mon, Apr 15, 20241.531.551.501.532,317,7252.32m
Friday, April 12, 2024Fri, Apr 12, 20241.581.601.501.535,511,6715.51m
Thursday, April 11, 2024Thu, Apr 11, 20241.581.601.551.583,146,3353.15m
Wednesday, April 10, 2024Wed, Apr 10, 20241.651.701.561.585,609,4125.61m
Tuesday, April 09, 2024Tue, Apr 09, 20241.701.751.531.658,103,0768.10m
Monday, April 08, 2024Mon, Apr 08, 20241.701.751.651.704,603,2824.60m
Friday, April 05, 2024Fri, Apr 05, 20241.781.801.631.707,817,9717.82m
Thursday, April 04, 2024Thu, Apr 04, 20241.851.901.751.785,886,4165.89m
Data delayed at least 20 minutes, as of May 03 2024 18:07 BST.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.